Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
ConditionCancers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeUp to 11
SponsorErin Rowell
About this trial
The purpose of this study is to safely remove ovarian tissue in pre-pubertal pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and hormone function.
Eligibility criteria
Qualifiers
Pre- Pubertal Individual
cyclophosphamide cumulative dose ≥7.5 g/m2
any treatment regimen containing procarbazine
busulfan cumulative dose >600 mg/m2
Disqualifiers
Patients with no anticipated oncologic therapies
Post-pubertal individuals
Pregnant children
Children with one ovary
Trial design
Treatments tested in this trial
- Laparoscopic surgery
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Erin Rowell
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Sponsor institution
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Source ClinicalTrials.gov